Form 8-K - Current report:
SEC Accession No. 0001293971-24-000028
Filing Date
2024-08-23
Accepted
2024-08-23 16:06:48
Documents
14
Period of Report
2024-08-20
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K blue-20240820.htm   iXBRL 8-K 36079
2 EX-99.1 exhibit99120240820.htm EX-99.1 10501
  Complete submission text file 0001293971-24-000028.txt   175992

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT blue-20240820.xsd EX-101.SCH 1913
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT blue-20240820_lab.xml EX-101.LAB 21880
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT blue-20240820_pre.xml EX-101.PRE 12516
16 EXTRACTED XBRL INSTANCE DOCUMENT blue-20240820_htm.xml XML 2718
Mailing Address 455 GRAND UNION BOULEVARD SOMERVILLE MA 02145
Business Address 455 GRAND UNION BOULEVARD SOMERVILLE MA 02145 339-499-9300
bluebird bio, Inc. (Filer) CIK: 0001293971 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35966 | Film No.: 241236338
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)